Non-ARV/Non-Hormonal Multi-Purpose Vaginal Ring
The non-antiretroviral, non-hormonal intravaginal ring developed by the Oak Crest Institute of Science is a multipurpose prevention technology with a 1-to 3-month duration combining two novel, luminally acting active pharmaceutical ingredients: (1) an anti-viral with unique mechanisms of action against HIV, HSV, and HPV; and (2) a contraceptive and would be a game-changer product for women who desire non-hormonal contraceptives with prevention of HIV and other sexually transmitted infections in a single product. Gathering end-user feedback early in the design phase will be prioritized. First-in-human trials will evaluate the safety and pharmacokinetics of the multipurpose prevention technology.
Development Stage:
Pre-formulation
Hormonal/Non-Hormonal:
Non-Hormonal
Delivery Route & Method:
Intravaginal - Intravaginal Ring (IVR)
Developer:
- Oak Crest Institute of Science
Funding:
- U.S. Agency for International Development (USAID)
Active Ingredient(s):
- Unspecified
Product Indication(s):
- HIV
- HPV
- HSV-1
- HSV-2
- Pregnancy